**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no
implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information
is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Acoustic Neuroma Association of Canada
a/k/a: ANAC
Address:
171A Rink Street, Suite 163
Ontario, K9J 2J6
Canada
Phone: (78-0) -428-3384
Fax: (78-0) -428-3909
800 Number: (80-0) -561-2622
Email Address: info@anac.ca
The Acoustic Neuroma Association of Canada (ANAC) is a non-profit, self-help organization dedicated to providing a comfortable environment for people who have or are facing the removal of acoustic neuromas and other tumors involving the cranial nerves. Acoustic neuromas are benign (noncancerous) tumors affecting the eighth cranial nerve, which is located in the auditory canal of the ear. Established in 1984, ANAC provides support; furnishes information on patient rehabilitation to physicians and healthcare personnel interested in the treatment of benign tumors and the alleviation of post-surgical problems; and promotes and supports research on the cause, development, and treatment of acoustic neuromas. ANAC consists of 500 members and produces educational materials including a quarterly newsletter titled, "The Connection," a pamphlet on acoustic neuroma, and a brochure titled, "The Hope is Recognition and Treatment." Program activities include regular support group meetings, patient advocacy, patient networking and patient education.
Chapters: 10
Website: http://www.anac.ca
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted
by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to
the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes
without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on
an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source
(NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed
versions are strictly prohibited.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.